NCT06723626View on ClinicalTrials.gov

Effects of Intravenous Metabolic Recovery Agent in Elderly Septic Patients on Prognosis and Microcirculation.

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Septic Shock
Interventions
DRUG

Metabolic resuscitation agent

Intervention group will receive intravenous hydrocortisone (200mg every 24 hours), vitamin C (1.5g every 6 hours), and thiamine (200 mg every 12 hours).

DRUG

Hydrocortisone

Placebo group will receive intravenous hydrocortisone 200mg every 24 hours.

Trial Locations (1)

210009

RECRUITING

Zhongda Hospital Southeast University, Nanjing

All Listed Sponsors
lead

Southeast University, China

OTHER